OPKO Health
OPK
#6210
Rank
โ‚ฌ0.91 B
Marketcap
1,23ย โ‚ฌ
Share price
0.73%
Change (1 day)
-8.18%
Change (1 year)

EPS for OPKO Health (OPK)

EPS in 2026 (TTM): -0,07773ย โ‚ฌ

According to OPKO Health 's latest financial reports the company's current EPS (TTM) is -0,08032ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,27ย โ‚ฌ a decrease over its 2024 EPS that were of -0,06247ย โ‚ฌ.

EPS history for OPKO Health from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,07773ย โ‚ฌ-70.97%
2025-0,27ย โ‚ฌ328.57%
2024-0,06247ย โ‚ฌ-72%
2023-0,22ย โ‚ฌ-43.18%
2022-0,39ย โ‚ฌ780%
2021-0,04462ย โ‚ฌ-200%
20200,04462ย โ‚ฌ-109.43%
2019-0,47ย โ‚ฌ96.3%
2018-0,24ย โ‚ฌ-49.06%
2017-0,47ย โ‚ฌ1225%
2016-0,03570ย โ‚ฌ-54.06%
2015-0,07770ย โ‚ฌ-78.23%
2014-0,36ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,79ย โ‚ฌ-9,804.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
2,78ย โ‚ฌ-3,564.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
37,40ย โ‚ฌ-46,666.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
4,05ย โ‚ฌ-5,144.44%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
10,86ย โ‚ฌ-13,622.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
4,93ย โ‚ฌ-6,244.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
0,56ย โ‚ฌ-800.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Ardelyx
ARDX
-0,20ย โ‚ฌ 144.44%๐Ÿ‡บ๐Ÿ‡ธ USA